Literature DB >> 14769962

Targeted gene modification using triplex-forming oligonucleotides.

Jean Y Kuan1, Peter M Glazer.   

Abstract

In recent years, triplex-forming oligonucleotides (TFOs) have emerged as powerful tools for site-specific gene modification. Their sequence specificity, binding affinity, and ability to provoke repair and recombination make them promising reagents for altering gene expression. This chapter highlights the binding requirements for triplex formation, identifies a number of chemical modifications that have been used with some success, and discusses studies using TFOs for inhibiting transcription. It also reviews work done using TFOs and related molecules to direct site-specific DNA damage, inducing mutagenesis or sensitizing a site to recombination. TFOs were initially used as positioning devices for nonspecific mutagens but were later discovered to have mutagenic properties of their own in cells with functional nucleotide excision repair (NER) and transcription-coupled repair (TCR) pathways. In subsequent studies triplex formation was able to induce both intramolecular and intermolecular homologous recombination, revealing its potential application for gene therapy. Recent reports demonstrate the ability of these molecules to locate and modify their cognate sites in chromosomal DNA in both cell culture and live animals, laying the foundation for triplex technology in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769962     DOI: 10.1385/1-59259-761-0:173

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Molecular recognition via triplex formation of mixed purine/pyrimidine DNA sequences using oligoTRIPs.

Authors:  Jian-Sen Li; Fa-Xian Chen; Ronald Shikiya; Luis A Marky; Barry Gold
Journal:  J Am Chem Soc       Date:  2005-09-14       Impact factor: 15.419

2.  Intramolecular recombination R-triplex in solution: stabilization by bis-intercalator YOYO.

Authors:  Dmitry N Kaluzhny; Vladimir V Timoshin; Olga F Borisova; Victor B Zhurkin; Vladimir L Florentiev; Anna K Shchyolkina
Journal:  J Biomol Struct Dyn       Date:  2008-12

Review 3.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21

4.  Regulation of transcription through light-activation and light-deactivation of triplex-forming oligonucleotides in mammalian cells.

Authors:  Jeane M Govan; Rajendra Uprety; James Hemphill; Mark O Lively; Alexander Deiters
Journal:  ACS Chem Biol       Date:  2012-05-11       Impact factor: 5.100

5.  Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.

Authors:  Erika Brunet; Maddalena Corgnali; Loïc Perrouault; Victoria Roig; Ulysse Asseline; Mads D Sørensen; B Ravindra Babu; Jesper Wengel; Carine Giovannangeli
Journal:  Nucleic Acids Res       Date:  2005-07-27       Impact factor: 16.971

Review 6.  The triple helix: 50 years later, the outcome.

Authors:  Maria Duca; Pierre Vekhoff; Kahina Oussedik; Ludovic Halby; Paola B Arimondo
Journal:  Nucleic Acids Res       Date:  2008-08-01       Impact factor: 16.971

7.  Mechanisms of precise genome editing using oligonucleotide donors.

Authors:  Yinan Kan; Brian Ruis; Taylor Takasugi; Eric A Hendrickson
Journal:  Genome Res       Date:  2017-03-29       Impact factor: 9.043

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.